19 October 2026

strategyland.uk

Spire Healthcare Group PLC (SPI)

Rank #178 of 280 - Healthcare - UK Equities

Home/Stocks/Healthcare

Spire Healthcare Group PLC

SPI.L·Healthcare·Market Cap £994m

Rank #178 of 280

Quantitative Model · 280 Stocks Analysed

£2.47

+47.90% YTD

52W: £1.41 - £2.49

Factor Analysis Summary

Editorial assessment generated from Spire Healthcare Group PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, Spire Healthcare Group PLC (SPI.L) currently holds an overall rank of #178 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include technical (RSI 66.7), where it demonstrates positive technical momentum with price action supporting a constructive trend, and asset efficiency, where it demonstrates above-average asset turnover and productive use of invested capital.

Areas requiring attention include solvency (debt/equity 1.8), where higher debt levels or weaker coverage ratios raise solvency concerns, as well as liquidity, where thin trading volumes could increase transaction costs and slippage.

Within the Healthcare sector, Spire Healthcare Group PLC sits at composite rank #178, trailing the Healthcare peer average (rank 77). It ranks behind all 6 tracked Healthcare peers in our model.

The composite profile is weighed down by 5 below-average factor scores, with solvency (rank 262/280) representing the most significant drag on its #178 overall standing.

Strongest Factors

Technical — Rank 56/280 (top quartile)
Asset Efficiency — Rank 75/280 (above average)
Valuation — Rank 210/280 (below average)

Weakest Factors

Solvency — Rank 262/280 (below average)
Liquidity — Rank 254/280 (below average)

Score Analysis

Spire Healthcare Group PLC is ranked #178 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

186/280

Average Score

Liquidity

Weak254/280

Valuation

Weak210/280

Profitability

Weak216/280

Solvency

Weak262/280

Asset Efficiency

Good75/280

Mkt Trading

Weak230/280

Technical

Excellent56/280

1. Liquidity

Score: 254/280

How liquid is SPI and can it meet its short-term obligations?

0/6

liquidity criteria met

Metric

Sector Range

Value

Rank

✗

Quick Ratio

1.0 - 2.5

0.49xRank 129/280

Range: 1.0 - 2.5Rank 129/280

✗

Current Ratio

1.5 - 2.5

0.63xRank 207/280

Range: 1.5 - 2.5Rank 207/280

✗

TTM Operating Cash Flow

0.8 - 1.5

0.38xRank 142/280

Range: 0.8 - 1.5Rank 142/280

–

Liquidity Coverage Ratio

N/A

Range: N/A

✗

Intangible Asset Ratio

5 - 20

0.01xRank 143/280

Range: 5 - 20Rank 143/280

✗

Cash-to-Debt Ratio

0.4 - 1.2

0.03xRank 238/280

Range: 0.4 - 1.2Rank 238/280

Key Liquidity Metrics

Quick Ratio

0.49x

Sector: 1.0 - 2.5

Current Ratio

0.63x

Sector: 1.5 - 2.5

Overall Liquidity Rank

Rank within universe#254/280

Best (1)Worst (280)

2. Valuation

Score: 210/280

Is SPI undervalued compared to its peers and fair value metrics?

3/7

valuation criteria met

Metric

Sector Range

Value

Rank

✗

FY27e P/E

15x - 30x

13.5xRank 143/280

Range: 15x - 30xRank 143/280

✓

FY26e P/E

15x - 30x

20.1xRank 181/280

Range: 15x - 30xRank 181/280

✓

FY27e Net Div Yld (%)

1.5 - 4.5

1.91%Rank 176/280

Range: 1.5 - 4.5Rank 176/280

–

Div Payout Ratio

30 - 60

N/ARank 25/280

Range: 30 - 60Rank 25/280

✗

Current EV/EBITDA

9.0x - 16.0x

7.4xRank 117/280

Range: 9.0x - 16.0xRank 117/280

✓

Current P/TBV

2.0x - 7.0x

2.26xRank 134/280

Range: 2.0x - 7.0xRank 134/280

✗

Current P/B

2.0x - 6.0x

0.91xRank 56/280

Range: 2.0x - 6.0xRank 56/280

Key Valuation Metrics

TTM P/E

Price-to-Earnings

N/A

FY26e P/E

Forward estimate

20.1x

FY27e P/E

Forward estimate

13.5x

Current P/B

Price-to-Book

0.91x

Current P/TBV

Tangible Book Value

2.26x

Current EV/EBITDA

Enterprise Value

7.4x

FY26e EV/EBITDA

Forward estimate

7.2x

FY27e EV/EBITDA

Forward estimate

7.1x

Dividend

SPI pays a dividend yield of 0.70%.

Current Yield

0.70%

FY27e Net Div Yield

1.91%

FY26e Gross DPS

0.030

FY27e Gross DPS

0.047

Dividend Per Share Forecast

3. Profitability

Score: 216/280

How profitable is SPI relative to its peers?

0/7

profitability criteria met

Metric

Sector Range

Value

Rank

✗

TTM Profit Margin

6 - 15

-0.1%Rank 255/280

Range: 6 - 15Rank 255/280

✗

T12 FCF Margin

12 - 20

0.2%Rank 148/280

Range: 12 - 20Rank 148/280

✗

FY27e RoE

12 - 25

9.4%Rank 156/280

Range: 12 - 25Rank 156/280

✗

FY26 EPS Growth

8 - 15

29.4%Rank 44/280

Range: 8 - 15Rank 44/280

✗

FY27e EPS Growth

8 - 15

92.8%Rank 24/280

Range: 8 - 15Rank 24/280

–

NIM

N/A

Range: N/A

–

Expense Ratio

75 - 87

N/A

Range: 75 - 87

TTM Profit Margin

-0.1%

Current RoCE

2.2%

FY27e RoE

9.4%

T12 FCF Margin

0.2%

EPS Growth

4. Solvency

Score: 262/280

How strong is SPI's balance sheet and financial position?

1/6

solvency criteria met

Metric

Sector Range

Value

Rank

✗

Debt/Eqt

0.2x - 0.7x

1.77xRank 233/280

Range: 0.2x - 0.7xRank 233/280

–

Interest Coverage Ratio

5x - 15x

Rank 239Rank 239/280

Range: 5x - 15xRank 239/280

✓

Net Leverage Ratio

0.5x - 1.5x

0.92xRank 68/280

Range: 0.5x - 1.5xRank 68/280

–

Altman Z-Score (Manufacturing)

<1.10 - >2.60

0.37Rank 234/280

Range: <1.10 - >2.60Rank 234/280

–

Z-Score (Non Manufacturing)

<1.10 - >2.60

Rank 231Rank 231/280

Range: <1.10 - >2.60Rank 231/280

–

CapAdeq Ratio Tier1

N/A

Range: N/A

Key Solvency Metrics

Debt/Eqt

1.77x

Net Leverage Ratio

0.92x

Interest Coverage

Rank 239

T12 FCF Margin

0.2%

Altman Z-Score

0.37

Distress Zone

01.812.995+

5. Asset Efficiency

Score: 75/280

How efficiently does SPI deploy its assets and intellectual capital?

0/5

asset efficiency criteria met

Metric

Sector Range

Value

Rank

–

Efficiency Ratio

N/A

Range: N/A

✗

TTM Asset Turnover Ratio

0.3x - 0.6x

0.67xRank 93/280

Range: 0.3x - 0.6xRank 93/280

✗

TTM CAPEX/Sales

6 - 10

4.1%Rank 104/280

Range: 6 - 10Rank 104/280

–

Working Capital Turnover

4x - 7x

N/A

Range: 4x - 7x

–

R&D/Sales FY27e

12 - 25

N/A

Range: 12 - 25

Overall Asset Efficiency Rank

Rank within sector peers#75/280

Best (1)Worst (280)

6. Market Trading

Score: 230/280

How liquid and actively traded is SPI?

1/2

market trading criteria met

Metric

Sector Range

Value

Rank

✗

Intraday Sentiment (%)

30 - 60

80.0%Rank 47/280

Range: 30 - 60Rank 47/280

–

10D-Avg v/s 3M-Avg Vol

N/A

117%Rank 50/280

Range: N/ARank 50/280

✓

Avg Directional Index 30D

010 - 40

13.9Rank 243/280

Range: 010 - 40Rank 243/280

–

Parabolic SAR

N/A

246.50Rank 220/280

Range: N/ARank 220/280

–

Stock Rating Rank

N/A

Rank 50Rank 50/280

Range: N/ARank 50/280

Market Cap

£994,289,991

Enterprise Value

£2,273,316,210

Trading Volume

7. Technical

Score: 56/280

What do the technical indicators say about SPI?

0/5

technical criteria met

Metric

Chart

Sector Range

Value

Rank

–

CMP v/s 52-WH

£2.49£1.41

-0.8%CMP: £2.47

N/A

-0.8%Rank 11/280

£2.49£1.41

-0.8%CMP: £2.47

Range: N/ARank 11/280

–

CMP v/s 52-WL

£2.49£1.41

+75.4%CMP: £2.47

N/A

75.4%Rank 254/280

£2.49£1.41

+75.4%CMP: £2.47

Range: N/ARank 254/280

–

RSI 14D

066.7 - Bullish100

N/A

66.7Rank 50/280

066.7 - Bullish100

Range: N/ARank 50/280

–

MA50 - MA200

£2.05+0.35£2.40

N/A

BullishRank 93/280

£2.05+0.35£2.40

Range: N/ARank 93/280

–

MACD Rank

Golden Cross

MACD: -0.42

N/A

-0.42

Golden Cross

MACD: -0.42

Range: N/A

RSI (14 Day)

66.7

Bullish

0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£2.40

200 SMA£2.05

SignalGolden Cross (Bullish)

MACD-0.42

Risk Metrics

Beta

N/A

3-Yr Std Dev

N/A

5-Yr Std Dev

N/A

Peer Comparison

How does SPI compare to other Healthcare stocks?

Overall Rank Comparison

Factor Score Comparison

Stock	Rank	Liquidity	Valuation	Profitability	Solvency	Mkt Trading	Technical
SPI	#178	254	210	216	262	230	56
AZN.L	#4	68	242	82	111	33	248
GNS.L	#63	33	133	153	79	96	277
HIK.L	#73	52	127	186	144	180	107
CVSG.L	#90	60	211	200	191	200	78
CTEC.L	#115	36	182	206	147	236	211
ONT.L	#118	28	114	262	128	64	205

Similar Stocks

Other top-ranked stocks in the Healthcare sector

Hikma Pharmaceuticals PLC

Oxford Nanopore Technologies PLC

Rank #118Score: 134

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

Methodology Note

The analysis presented for Spire Healthcare Group PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Strategyland Research Center - strategyland.ukThis report is for informational purposes only. Not financial advice.